AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • ISSN:
      0168-8278
    • Accession Number:
      10.1016/S0168-8278(20)30731-5
    • Accession Number:
      S0168827820307315
    • Copyright:
      Copyright © 2020 European Association for the Study of the Liver on behalf of European Association for the Study of the Liver All rights reserved.
  • Citations
    • ABNT:
      IAVARONE, M. et al. AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care. Journal of Hepatology, [s. l.], v. 73, n. Supplement 1, p. S103–S104, 2020. DOI 10.1016/S0168-8278(20)30731-5. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edselp&AN=S0168827820307315. Acesso em: 1 dez. 2020.
    • AMA:
      Iavarone M, Invernizzi F, Zavaglia C, et al. AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care. Journal of Hepatology. 2020;73(Supplement 1):S103-S104. doi:10.1016/S0168-8278(20)30731-5
    • APA:
      Iavarone, M., Invernizzi, F., Zavaglia, C., Zamparelli, M. S., Fraile, M., Czauderna, C., Di Costanzo, G., Bhoori, S., Pinter, M., Manini, M. A., Amaddeo, G., Fernandez, A., Pinero, F., Blanco Rodriguez, M. J., Anders, M. M., Aballay Soteras, G. A., Villadsen, G. E., Cesarini, L., Mazza, S., … Reig, M. (2020). AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care. Journal of Hepatology, 73(Supplement 1), S103–S104. https://doi.org/10.1016/S0168-8278(20)30731-5
    • Chicago/Turabian: Author-Date:
      Iavarone, Massimo, Federica Invernizzi, Claudio Zavaglia, Marco Sanduzzi Zamparelli, Miguel Fraile, Carolin Czauderna, Giuseppe Di Costanzo, et al. 2020. “AS150 - Regorafenib Improves Survival after Sorafenib Treatment in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation, Compared to Best Supportive Care.” Journal of Hepatology 73 (Supplement 1): S103–4. doi:10.1016/S0168-8278(20)30731-5.
    • Harvard:
      Iavarone, M. et al. (2020) ‘AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care’, Journal of Hepatology, 73(Supplement 1), pp. S103–S104. doi: 10.1016/S0168-8278(20)30731-5.
    • Harvard: Australian:
      Iavarone, M, Invernizzi, F, Zavaglia, C, Zamparelli, MS, Fraile, M, Czauderna, C, Di Costanzo, G, Bhoori, S, Pinter, M, Manini, MA, Amaddeo, G, Fernandez, A, Pinero, F, Blanco Rodriguez, MJ, Anders, MM, Aballay Soteras, GA, Villadsen, GE, Cesarini, L, Mazza, S, Díaz-Gonzázlez, Á, Gonzalez Dieguez, ML, Tortora, R, Weinmann, A, Mazzaferro, V, Romero, M, Crespo, G, Regnault, H, De Giorgio, M, Varela, M, Donato, MF, Worns, M-A, Bruix, J, Lampertico, P & Reig, M 2020, ‘AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care’, Journal of Hepatology, vol. 73, no. Supplement 1, pp. S103–S104, viewed 1 December 2020, .
    • MLA:
      Iavarone, Massimo, et al. “AS150 - Regorafenib Improves Survival after Sorafenib Treatment in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation, Compared to Best Supportive Care.” Journal of Hepatology, vol. 73, no. Supplement 1, Aug. 2020, pp. S103–S104. EBSCOhost, doi:10.1016/S0168-8278(20)30731-5.
    • Chicago/Turabian: Humanities:
      Iavarone, Massimo, Federica Invernizzi, Claudio Zavaglia, Marco Sanduzzi Zamparelli, Miguel Fraile, Carolin Czauderna, Giuseppe Di Costanzo, et al. “AS150 - Regorafenib Improves Survival after Sorafenib Treatment in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation, Compared to Best Supportive Care.” Journal of Hepatology 73, no. Supplement 1 (August 1, 2020): S103–4. doi:10.1016/S0168-8278(20)30731-5.
    • Vancouver/ICMJE:
      Iavarone M, Invernizzi F, Zavaglia C, Zamparelli MS, Fraile M, Czauderna C, et al. AS150 - Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care. Journal of Hepatology [Internet]. 2020 Aug 1 [cited 2020 Dec 1];73(Supplement 1):S103–4. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edselp&AN=S0168827820307315